Prof. Dr. Evrim Kadriye Tezcanlı
Radiation Oncology
About Evrim Kadriye Tezcanlı
Prof. Evrim Kadriye Tezcanlı is a board-certified radiation oncologist with a long-standing commitment to patient-centered cancer care. She graduated from Marmara University Faculty of Medicine in 2005 and completed specialized training in Radiation Oncology. Since 2020, she has been practicing at Acibadem Health Group, where she provides advanced radiation therapy and collaborates with multidisciplinary teams to design individualized treatment plans. Prof. Tezcanlı is an active member of the Radiation Oncology Society and the Turkish Oncology Society, contributing to professional development and staying current with advances in cancer treatment. Known for her clinical expertise and compassionate approach, she focuses on combining evidence-based techniques with attention to patients’ quality of life.
Subspecialties
- High-grade recurrent gliomas
- Glioblastoma multiforme
- Oligodendroglial tumors
- Nasopharyngeal tumors
- Bladder tumors
- Locally advanced pancreatic cancer
- Colorectal cancer
- External beam radiotherapy
- Stereotactic radiosurgery
- Chemoradiotherapy
- Concurrent gemcitabine radiotherapy
- Radiation therapy treatment planning
Education
- 2005 Marmara University Faculty of Medicine Radiation Oncology
- 1995 – 2000 Istanbul University Istanbul Faculty of Medicine
- 1992 – 1995 Gazi Anatolian High School
Experience
- 2020 Acibadem Health Group
Professional Memberships
- Radiation Oncology Society
- Turkish Oncology Society
Selected Publications
- Tolerability and efficacy of temozolomide in high-grade relapsed glims E. Tezcanlı, U. Abacıoğlu, H. Çağlar, P.F. Yumuk, M. Şengöz, XVI: National Cancer Congress 2005, P106
- Characteristics of patients with nasopharyngeal tumors who underwent stereotactic radiosurgery after external radiotherapy B. M. Atasoy, E. Tezcanlı, Z. Akgün, S. Peker, U. Abacıoğlu, T. Kılıç, M. Şengöz, N. Pamir, XVI National Cancer Congress 2005, P92
- Outcomes of chemoradiotherapy for patients with bladder tumors İ. Çetin, Z. Akgün, H. Çağlar, E. Tezcanlı, U. Abacıoğlu, M. Şengöz, F. Yumuk, S. Turhal, XVI. National Cancer Congress 2005, P60
- Prognostic signifiance of MIB-1 labeling indices for oligodendroglial tumors Abacioglu U, Sengoz M, Tezcanli E, Akbulat S, Peker S, Sav A, Proceeding ASCO, 122s, Orlando, 2005
- Toxicity and survival outcomes of radiotherapy and concurrent gemcitabine in patients with locally advanced pancreatic cancer H. Çağlar, U Abacıoğlu, E. Tezcanlı, F. Yumuk, S. Turhal, M. Şengöz, 6th National Radiation Oncology Congress
- Turkish translation and pilot-test study of EORTC colorectal cancer module QLQ-CR 38” in evaluating the quality of life of colorectal cancer patients, 6th National Radiation Oncology Congress U Abacıoğlu, Ö,.F. Odabaş, E. Tezcanlı, F. Yumuk, H. Çağlar, P.F. Yumuk, M. Şengöz, S.Tufhal
- Ki-67 proliferation index as a prognostic factor in Glioblastoma Multiforme Abacioglu U, Sengoz M, Tezcanli E, Akbulut S, Peker S, Sav A. Perspective in Central Nervous System Malignancies, 166, Prague, 2005
- Tolerability and efficacy of temozolomide in high-grade recurrent gliomas U. Abacıoğlu, M. Şengöz, E. Tezcanlı, H. Çağlar, P.F. Yumuk, 6th National Radiation Oncology Congress, P223
Schedule your appointment with Prof. Dr. Evrim Kadriye Tezcanlı
Choose a date and time that suits you. Our international patient team will check availability and confirm your appointment — usually within 24 hours.
- 1Choose your date & timePick a preferred day and time slot for your visit.
- 2Share your detailsTell us how to reach you and anything we should know.
- 3We confirm with youOur team confirms the appointment by phone or email.
Request your appointment
This request goes directly to this doctor’s schedule.
Your information stays strictly confidential and is used only to arrange your care.